Form 8-K - Current report:
SEC Accession No. 0001193125-25-156413
Filing Date
2025-07-08
Accepted
2025-07-08 06:26:16
Documents
15
Period of Report
2025-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d74755d8k.htm   iXBRL 8-K 57957
2 EX-2.1 d74755dex21.htm EX-2.1 521140
3 EX-10.1 d74755dex101.htm EX-10.1 119707
4 EX-99.1 d74755dex991.htm EX-99.1 11840
  Complete submission text file 0001193125-25-156413.txt   1005790

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crgx-20250707.xsd EX-101.SCH 2841
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crgx-20250707_lab.xml EX-101.LAB 18737
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crgx-20250707_pre.xml EX-101.PRE 11701
17 EXTRACTED XBRL INSTANCE DOCUMENT d74755d8k_htm.xml XML 3771
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-499-8950
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

EIN.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 251109492
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)